TELO Genomics Expands Multi-Center Studies Comparing TELO-MRD With Sequencing
TELO Genomics said it is expanding multi-center clinical studies to compare TELO-MRD with next-generation sequencing.
Related stories
S&P 500 E-mini Futures Fall 0.9%, Nasdaq 100 Futures Drop 2%
Dow futures were flat.
M impact | EQUITY | Oct 30, 2026, 07:29 AM UTC
Deutsche Bank raises Aixtron to Buy from Hold
Deutsche Bank raised its rating on Aixtron to Buy from Hold.
M impact | EQUITY | Oct 30, 2026, 07:29 AM UTC
Amazon Shares Fall 7.21% After Hours
Amazon shares fell 7.21% in after-hours trading.
M impact | EQUITY | Oct 30, 2026, 07:25 AM UTC
Ueda Says Trading Volume Fell Short of Assumption in BOJ ETF Sales Decision
BOJ Governor Kazuo Ueda said market trading volume increased, while actual volume was below the level initially assumed in the decision to accelerate ETF sales.
M impact | EQUITY | Oct 30, 2026, 07:24 AM UTC
Sylvania Platinum Q1 Revenue Rises 30% on Record PGM Output
Sylvania Platinum reported a 30% rise in Q1 revenue alongside record PGM output.
M impact | EQUITY | Oct 30, 2026, 07:24 AM UTC
Alphabet shares plunge 12.6% amid AI profitability doubts
Alphabet shares fell 12.6%; the report cites doubts about AI profitability.
H impact | EQUITY | Oct 30, 2026, 07:24 AM UTC